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ABSTRACT 
Introduction: Few lung cancer screening decision aids have been tested in diverse populations. 
The study objective was to determine whether the online decision 
aid www.shouldiscreen.com impacts knowledge of and decisional conflict around lung cancer 
screening in a diverse population. 
Methods: Eligible patients had significant smoking histories, were at increased risk for lung 
cancer (ages 45-80, >20 pack-years, smoking within last 15 years) and had no history of prior lung 
cancer or screening. Data was collected and analyzed in 2017. 
Results: 40 patients were enrolled: 80% were female, 62.5% black, 33% white, and 48% had a 
high school education or less. 80% were current smokers with a mean of 34 pack-years 
accumulated. 35% were eligible for screening by U.S. Preventive Services Task Force criteria. 
After reviewing the decision aid, knowledge increased in all categories including risk factors for 
lung cancer (3.58 to 4.30, p<0.01), benefits of screening (1.58 to 2.30, p<0.01), possible harms of 
screening (0.93 to 2.08, p<0.01), and eligibility for screening (2.10 to 2.65, p<0.01). Decisional 
conflict was reduced from 21.25 to 8.65 (p<0.01). After use of the decision aid, more patients 
expressed a preference not to be screened for lung cancer, such that concordance with USPSTF 
guidelines decreased among those who were eligible to screen increased among those who did not 
yet meet eligibility criteria; however, this finding was not statistically significant. 
Conclusions: Even brief, unguided use of this web-based tool improved knowledge and reduced 
decisional conflict for a diverse group of smokers considering lung cancer screening. 
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INTRODUCTION 
For many years, screening programs for breast, cervical, and colorectal cancer have 
enjoyed the privilege of generally well-publicized and understood screening practices. As such, 
many individuals at highest risk for mortality have been screened through mammography, pap 
smears, and colonoscopy. However, few such organized efforts exist for lung cancer, the second 
most common cause of cancer and the most common cause of cancer deaths in both men and 
women in the United States (American Cancer Society, 2016). Lung cancer is often diagnosed at 
late stages and carries a high but modifiable mortality. The aim of this study was to better 
understand how to educate patients about lung cancer screening harms and potential benefits. 
Specifically, we evaluated the efficacy of one online decision aid in improving knowledge of and 
reducing decisional conflict around lung cancer screening. 
The field of lung cancer screening has changed significantly over the past decade since the 
National Lung Screening Trial demonstrated a 20% reduction in mortality with annual low-dose 
computed tomography (LDCT) in patients at high risk for lung cancer (National Lung Screening 
Trial Research Team, 2011). Based on these trials, the United States Preventative Services Task 
Force (USPSTF) currently recommends annual screening for lung cancer with LDCT in adults 
ages 55-80 who have a 30 pack-year smoking history and currently smoke or quit within the last 
15 years (Moyer, 2014). Once high-risk individuals have been identified and referred for 
screening, they must undergo shared decision-making so as to understand the benefits and risks of 
screening, including false-positives, incidental findings, over diagnosis, and radiation risk.  Shared 
decision making is recommended by the USPSTF, American Cancer Society, American Academy 
of Family Physicians, National Comprehensive Cancer Network, and others (U.S. Preventative 
Services Task Force, 2016). In fact, the Center for Medicare and Medicaid Services mandates that 
shared decision-making occur as a stipulation of lung cancer screening reimbursement (U.S. 
Center for Medicare and Medicaid Services, 2015). 
Implementation of shared decision making about lung cancer screening has various 
challenges including low patient and provider awareness of the guidelines (Lewis, 2015), limited 
time during clinician visits, and variability of the process of shared decision making.  A 2018 study 
observed a small sample of recorded conversations about initiating lung cancer screening in which 
physicians did not use decision aids (Brenner et al., 2018). They found that the quality of shared 
decision making was poor and the discussion of the harms of screening was minimal. Several 
shared decision-making tools have been developed to improve the quality of such conversations 
(Reuland et al., 2018). An initial educational video-based decision aid was acceptable to patients 
and generally increased knowledge of lung cancer screening, but was not individualized and did 
not aid patients in making specific decisions (Volk et al., 2014). More recently, a web-based 
decision aid (www.shouldiscreen.com) was developed which describes individual cancer risks and 
screening impact given user-entered patient demographics (Lau et al., 2013). This tool was tested 
and shown to be acceptable to users, increase knowledge and concordance with USPSTF 
guidelines, and decrease decisional conflict. However, this was studied in a population of 60 
patients in Michigan in which 88% were white, 63% had at least a college degree, and only 18% 
were actually eligible for screening by USPSTF guidelines (Lau et al., 2015). Therefore, use of 
this decision aid should also be assessed among minority populations and those of lower 
socioeconomic status, such as Philadelphia. 
This study sought to assess the efficacy of the online decision aid 
(www.shouldiscreen.com) by replicating the study in a more ethnically and socioeconomically 
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diverse sample of patients. Our main aim was to understand how this online tool impacts 
knowledge of and decisional conflict around screening. Effective tools for shared-decision making 




An uncontrolled, paired sample before-and-after study was conducted with 40 participants 
to assess the efficacy of the online decision aid (January through May 2017). Participants were 
recruited from general pulmonology and smoking cessation clinics at the University of 
Pennsylvania and were current or former smokers, aged 45-80 years, who had accrued at least a 
20 pack-year smoking history, had smoked within the last 15 years, and had no prior history of 
lung cancer or LDCT lung cancer screening. Participants were offered the opportunity to view the 
decision aid at a computer in the clinic. No incentives were paid to participants. The study was 
approved by the University of Pennsylvania IRB. 
Data Collection 
Participants were directed to complete a questionnaire about demographics, smoking 
behaviors, knowledge of lung cancer screening, decisional conflict around screening, and 
readiness to screen. The questionnaire was administered via Qualtrics (www.qualtrics.com) at the 
University of Pennsylvania. Participants were asked to complete a “Before” questionnaire after 
which they were navigated to shouldiscreen.com. Participants were familiarized with the website 
layout and told to take their time in navigating through the general links on lung cancer screening 
and the personalized risk calculator. Once participants had viewed the website to their satisfaction 
they were directed to the “After” questionnaire. 
Measures  
Study questionnaires were adapted from the original validation study for 
shouldiscreen.com, which assessed knowledge of benefits and harms of lung cancer screening, 
decisional conflict, and concordance (Lau et al, 2015). These measures were originally based upon 
the Ottawa Decision Support Framework (O’Connor et al., 2011).Knowledge was assessed by 
asking a series of true-false questions about lung cancer risk factors (6 items), possible benefits (3) 
and harms of lung cancer screening (3), and yes/no questions about screening eligibility for four 
scenarios (4). There was an additional multiple-choice question asking what percentage of nodules 
found on CT would not be cancerous with a 5-point probability response scale that ranged from 
more than 90% to less than 5% (see Appendix-Table 2). The ten-item decisional conflict scale was 
composed of four subscales: uncertainty, informed, values clarity, and support. A total score of 0 
indicates no decisional conflict, whereas 100 shows extremely high conflict. Concordance was 
measured between USPSTF recommendations and each participant’s preference as to whether or 
not to undergo screening. This was assessed by the question Which option do you prefer now in 
terms of lung cancer screening?, which was asked before and after exposure to shouldiscreen.com. 
Participants who answered I prefer to screen and were also USPSTF eligible were deemed 
concordant, as were participants ineligible for screening who answered I prefer not to screen. 
Lastly, personalized lung cancer incidence risk was calculated on the shouldiscreen.com website 
using an established risk model (Tammemägi et al., 2013). 
Statistical Analysis 
Our primary endpoints were improvement in knowledge and reduction in decisional 
conflict after exposure to shouldiscreen.com as compared to baseline. With a total sample size of 
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40 participants, we had 87% power to detect a 50% absolute difference in knowledge and 
decisional conflict after exposure to shouldiscreen.com. The criterion for significance (alpha) was 
set at 0.050. Paired t-tests were used to assess changes in knowledge and decisional conflict from 
baseline to after exposure to shouldiscreen.com. All analyses were conducted using RStudio 
(Version 1.0.143) and a p-value of < 0.05 was considered to be statistically significant. 
 
RESULTS 
Of 160 patients who completed an initial triage questionnaire between January and May 
2017, 87 (54%) met inclusion criteria based on age and smoking status. Of the 62 participants that 
were excluded, 34 (54.8%) were due to insufficient pack years, 14 (22.6%) due to computer 
illiteracy, 7 (11.3%) due to lung cancer diagnosis, 3 (4.9%) due to visual or physical impairments 
rendering them unable to use the computer, 2 (3.2%) due to inability to speak English, and 2 (3.2%) 
due to having quit smoking more than 15 years ago. Of those eligible patients, 40 (46%) were 
consented and enrolled (Figure 1). For those participants that were eligible but chose not to enroll, 
their reasons included lack of time (77%), not interested in participating in research (19%), lack 
of financial incentive (2%), and not feeling well (2%). Compared to those who did not enroll, those 
who enrolled were more likely to be female (80% of those enrolled vs. 58% of those not enrolled). 
The average enrolled participant was aged 57 (standard deviation 6.41 years), 80% were female, 
and 62.5% were African-American (Table 1). 80% of participants were current smokers, and 35% 
met USPSTF eligibility criteria for lung cancer screening. Of those participants that were ineligible 
for screening, 50% were ineligible due to insufficient pack-years alone, 27% due to age alone, and 
23% due to both insufficient pack-years and age. Regarding 6-year lung cancer risk, 45% of 
participants had greater than 2% risk. Average time spent on the shouldiscreen.com decision aid 
was 9.6 minutes (range 3 to 19 min), and average total time for questionnaire completion was 28 
minutes (range 16 to 46 min). 
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Table 1. Participant demographics [Number of participants (%)] 
Total (N=40) 
Age, mean (SD, range) 
Female 
Race 
  Black/African-American 
  White 
  American Indian/Alaskan Native 
  Other 
Ethnicity 
  Hispanic or Latino 
  Not Hispanic or Latino 
Education 
  Less than high school 
  High school graduate 
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  Some training after high school 
  Some college 
  College graduate 
  Postgraduate or professional degree 
Smoking history 
  Current smoker 
  Quit within past 15 years 
  Pack years, mean, median (SD) 
  More than 30 pack-years 
Lung cancer risk 
  <1% risk 
  1-2% risk 
  >2% risk 
Eligible for screening by USPSTF criteria 
Ineligible for screening by USPSTF criteria   
  Ineligible due to pack-years alone 
  Ineligible due to age alone 
  Ineligible due to both pack-years and age 


















6 (23%)  
9.6 + 4.1 
 
Table 2 shows changes in knowledge, decisional conflict, and concordance, before and 
after exposure to shouldiscreen.com. Knowledge increased after reviewing the decision aid in all 
categories, including risk factors for lung cancer (3.58 to 4.30, p<0.01), benefits of lung cancer 
screening (1.58 to 2.30, p<0.01), possible harms of screening (0.93 to 2.08, p<0.01), and eligibility 
for screening (2.10 to 2.65, p<0.01). Additionally, mean overall decisional conflict was reduced 
from 21.25 to 8.65 (p<0.01) with improvements primarily across the subcategories of information, 
values clarity, and uncertainty.  
 
Table 2. Before and After Results for Knowledge, Decisional Conflict Scale, and Concordance.  







Factors that increase the chances of 
getting lung cancer [6] 
 
Possible benefits of lung cancer 
screening [3] 
 
Possible harms of lung cancer 
screening [3] 
 
Which individuals would be 
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given that they all meet smoking 
status and pack-year criteria? [1] 
 
What percentage of lumps found on 
your lung by the CT screening is 






















































Concordanced Overall concordance 
 
Concordance among USPSTF 
eligible 
 




















a- The overall maximum score for the knowledge section is 14. The maximum score of each specific question is 
specified in square parentheses. 
b-The figures presented for question 5 are the proportion of participants that answered correctly as there was only one 
correct answer. 
c-Lower scores in the Decisional Conflict Scale signify less decisional conflict. A score of lower than 25 is associated 
with implementing the decision. The overall score is the average of the subscales’ scores. 
d- Participants who preferred to get screened and were also eligible for screening based on USPSTF criteria were 
deemed “concordant” as were participants not eligible for screening who preferred not to get screened. The figures 
reported represent the frequency and proportion of those who were concordant.  
 
Overall, preference to screen declined after navigating shouldiscreen.com, such that more 
patients expressed a preference not to be screened for lung cancer. Specifically, concordance with 
USPSTF guidelines decreased among those who were eligible to screen and increased among those 
who did not yet meet eligibility criteria. However, these findings were not statistically significant. 
 
DISCUSSION: 
The web-based decision aid shouldiscreen.com was acceptable and feasible in a 
socioeconomically and racially diverse group of smokers. Use of the aid improved lung cancer 
screening knowledge and decreased decisional conflict, demonstrating its utility both as an 
informational and decision guiding tool. At baseline, participants exaggerated the potential 
benefits from screening, with only 7.5% correctly answering that >95% of lumps found on a 
screening CT would be non-cancerous. After use of the decision aid, 32.5% of participants 
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correctly answered this question, demonstrating a more accurate understanding of the potential 
benefits and harms of screening. With this, we saw an overall preference for screening decline 
after decision aid viewing. This may stem from the fact that benefits to screening are generally 
well publicized whereas risks of screening, such as false positives, subsequent unnecessary testing 
and possible complications, are less publicized. Use of the decision aid informed participants of 
the realistic potential benefits and harms of screening, and this may have in turn discouraged them 
from future screening. Future qualitative studies aimed at understanding patient attitudes towards 
screening after use of decision aids would help to expand on this finding. This finding highlights 
the importance of a structured tool in the shared decision-making process, as clinicians may be 
highly variable in their own attitudes towards screening and may thus present risks and benefits to 
patients in inconsistent or misleading ways (Ebell et al., 2018). The decision aid is not meant to 
replace a shared decision-making conversation. It is a tool and a starting point for such discussions, 
providing a patient with information and empowering them to assess their personalized risks and 
benefits through a discussion with their physician. 
Limitations 
This study is limited to a brief interaction with a lung cancer screening decision-aid, and 
its immediate impact on patient knowledge, attitude, and willingness to screen. The majority of 
participants were female which is problematic given that lung cancer accounts for the highest 
number of cancer deaths among African-American males in the U.S. (American Cancer Society, 
2019). Many African-American males were eligible and approached for the study, but chose not 
to participate. Future studies may benefit from offering a small monetary incentive to participants 
to improve enrollment. Additionally, only 35% of participants were USPSTF eligible for 
screening. The overall lung cancer risk was still higher than that seen in prior validation studies, 
and the overall low screening eligibility would be expected to contribute to the low post-decision 
aid willingness to screen as seen in our data.  
One major limitation of this study was the inclusion of patients 45 to 80 years old, whereas 
the current USPSTF criteria includes only patients 55 to 80 years old. The decision was made to 
include younger patients for multiple reasons: for one, all of the participants, including those 
younger than 55, had a >20 pack year smoking history and 80% of all participants were active 
smokers. Therefore, it is likely that the majority of the participants under 55 will be eligible for 
lung cancer screening in the coming decade if they continue to smoke. Additionally, patient 
populations that are at increased risk for lung cancer are not represented in the current lung cancer 
screening criteria (Wood et al., 2018). Research has shown that African-Americans have a higher 
risk of lung cancer than whites even if they smoke less over time, and are diagnosed with lung 
cancer at a younger age compared with whites (Aldrich et al., 2019).  Given this, the current 
USPSTF guidelines may be too conservative for African-American smokers, which comprised 
62.5% of our participant population. Other risk models have been developed to try to expand 
eligibility to such high-risk individuals that are not currently included in the USPSTF eligibility 
criteria (Tammemägi et al., 2014). One such study including U.S. ever smokers age 50-80 showed 
that a risk-based model for screening was associated with a greater number of lung cancer death 
prevented over 5 years when compared with the current USPSTF model (Katki et al., 2016). 
Since this was a single day study, there was no follow-up to see if knowledge gains were 
durable or if participants who preferred to get screening ever actually did so. However, one recent 
study demonstrated persistent knowledge gains one month after use of an online decision aid 
(Mazzone et al., 2017). Another study followed patients three months after exposure to an online 
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decision aid, and found heterogeneous screening behaviors (Reuland et al., 2018). Lastly, a 
limitation to our study was the requirement that participants have experience with computers in 
order to use the web-based tool. Of the 62 participants that were excluded, 14 (22.5%) were due 
to computer illiteracy and 3 (4.8%) were due to visual or physical impairments rendering them 
unable to use the computer. A recent study showed that use of audio in future decision aids may 
improve patient participation for those unable to use computers (Hoffman et al., 2018). Expansion 
to other languages would also allow for wider decision aid use. Since this study, a Spanish-
language version has been developed and can be found at the following website: 
www.shouldiscreen.com/Español/inicio. Future studies should address how best to effectively 
integrate such an intervention into current clinical practices or a larger lung cancer screening 
program, as a standalone decision aid could be viewed at home pre-visit or while waiting for a 
physician in the office but would require even more literacy and autonomy on the part of the 
patient. 
Finally, this study was a single-group, pre-post study and future work should include a 
usual care or control group in the design to determine if this decision aide is effective compared to 
usual care. 
Despite these limitations, this study shows that a web-based decision aid can be helpful 
tool for increasing knowledge and reducing decision conflict about lung cancer screening in a 
racial and ethnically diverse group of smokers in an urban academic clinic who are at increased 
risk of lung cancer.   
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